Aubry-Rozier B, Gonzalez-Rodriguez E, Stoll D, Lamy O
Center of Bone Diseases, Bone and Joint Department, Lausanne University Hospital, Av. Pierre-Decker 4, 1011, Lausanne, Switzerland.
Osteoporos Int. 2016 May;27(5):1923-5. doi: 10.1007/s00198-015-3380-y. Epub 2015 Oct 28.
Osteoporosis treatments are usually given for a limited period of time in order to balance benefits and risks. We report three cases of postmenopausal women without any previous fragility fracture who presented severe spontaneous vertebral fractures after denosumab discontinuation. We think that the occurrence of these fractures could be explained by the severe rebound effect observed after denosumab discontinuation and that a consensus regarding the end of treatment with denosumab has to be defined.
骨质疏松症治疗通常在有限的时间段内进行,以平衡获益与风险。我们报告了3例绝经后女性病例,她们既往无脆性骨折史,在停用地诺单抗后出现了严重的自发性椎体骨折。我们认为这些骨折的发生可能是由于停用 地诺单抗后观察到的严重反跳效应所致,并且必须就停止使用地诺单抗治疗达成共识。